** REVISION **
HOUSE OF REPRESENTATIVES

NOTICE OF PUBLIC HEARING

COMMITTEE:   Public Health 

TIME & DATE: 8:00 AM, Tuesday, April 18, 2017 

PLACE:       E2.012 
CHAIR:       Rep. Four Price 

HB 661        Parker
Relating to access to certain investigational drugs, biological products, and devices that are in clinical trials by patients with severe chronic diseases.

HB 810        Parker | et al.
Relating to the provision of certain investigational stem cell treatments to patients with certain severe chronic diseases or terminal illnesses.

HB 1158       Davis, Sarah
Relating to the content of an application for Medicaid.

HB 1398       Muñoz, Jr.
Relating to the processing and payment of claims for reimbursement by certain providers under the Medicaid program.

HB 1616       Thompson, Senfronia
Relating to an exemption from civil liability for certain professionals for the disclosure of certain mental health information.

HB 2118       Klick | et al.         
Relating to the regulation of the practice of physical therapy.

HB 2389       Burkett                
Relating to the supervision of pharmacist-interns, pharmacy technicians, and pharmacy technician trainees by a pharmacist and the adoption of rules by the Texas State Board of Pharmacy.

HB 2418       Cosper | et al.        
Relating to continuing education requirements for noncertified surgical technologists.

HB 2747       Zedler                 
Relating to eligibility for and grounds for disciplinary action applicable to a license to practice medicine.

HB 2765       Clardy                 
Relating to the Physical Therapy Licensure Compact; authorizing fees.

HB 3040       Burkett | et al.       
Relating to the continuation and functions of the Texas Medical Board; authorizing a fee.

HB 3083       Price                  
Relating to eligibility requirements for the repayment of certain mental health professional education loans.

HB 3183       Guillen                
Relating to the re-creation of the Chronic Kidney Disease Task Force.

HB 3236       Kacal                  
Relating to the costs associated with the provision of certain investigational drugs, biological products, and devices that are in clinical trials.

HB 3634       Bonnen, Greg           
Relating to the amendment of the Texas Health Care Transformation and Quality Improvement Program waiver.

HB 3721       Parker                 
Relating to the authority of the Cancer Prevention and Research Institute of Texas to administer the Texas Cancer Clinical Trials Program.

Bills added after last posting:

HB 1616

**         See Committee Coordinator for previous versions         **
of the schedule, if applicable.

NOTICE OF ASSISTANCE AT PUBLIC MEETINGS

Persons with disabilities who plan to attend this meeting and who may need assistance, such as a sign language interpreter, are requested to contact Stacey Nicchio at (512) 463-0850, 72 hours prior to the meeting so that appropriate arrangements can be made.